162 related articles for article (PubMed ID: 33362269)
1. Barriers, facilitators, and solutions to familial hypercholesterolemia treatment.
Jones LK; Sturm AC; Seaton TL; Gregor C; Gidding SS; Williams MS; Rahm AK
PLoS One; 2020; 15(12):e0244193. PubMed ID: 33362269
[TBL] [Abstract][Full Text] [Related]
2. Using implementation science to develop a familial hypercholesterolemia screening program in primary care: The CARE-FH study.
Jones LK; Romagnoli KM; Schubert TJ; Clegg K; Kirchner HL; Hu Y; Cawley D; Norelli V; Williams MS; Gidding SS; Rahm AK
J Clin Lipidol; 2024; 18(2):e176-e188. PubMed ID: 38228467
[TBL] [Abstract][Full Text] [Related]
3. Developing implementation strategies to improve uptake of guideline-recommended treatments for individuals with familial hypercholesterolemia: A protocol.
Jones LK; Gidding SS; Seaton TL; Goldberg A; Gregor C; Sturm AC; Brownson RC; Rahm AK; Williams MS
Res Social Adm Pharm; 2020 Mar; 16(3):390-395. PubMed ID: 31229402
[TBL] [Abstract][Full Text] [Related]
4. Familial hypercholesterolaemia reduces the quality of life of patients not reaching treatment targets.
Mortensen GL; Madsen IB; Kruse C; Bundgaard H
Dan Med J; 2016 May; 63(5):. PubMed ID: 27127013
[TBL] [Abstract][Full Text] [Related]
5. Barriers to and Facilitators of Implementing Guidelines for Detecting Familial Hypercholesterolaemia in Australia.
Sarkies MN; Testa L; Best S; Moullin JC; Sullivan D; Bishop W; Kostner K; Clifton P; Hare D; Brett T; Hutchinson K; Black A; Braithwaite J; Nicholls SJ; Kangaharan N; Pang J; Abhayaratna W; Horton A; Watts GF
Heart Lung Circ; 2023 Nov; 32(11):1347-1353. PubMed ID: 37865587
[TBL] [Abstract][Full Text] [Related]
6. Designing implementation strategies to improve identification, cascade testing, and management of families with familial hypercholesterolemia: An intervention mapping approach.
Jones LK; Calvo EM; Campbell-Salome G; Walters NL; Brangan A; Rodriguez G; Ahmed CD; Morgan KM; Gidding SS; Williams MS; Brownson RC; Seaton TL; Goldberg AC; McGowan MP; Rahm AK; Sturm AC
Front Health Serv; 2023; 3():1104311. PubMed ID: 37188259
[TBL] [Abstract][Full Text] [Related]
7. Assessment of medical intern's knowledge, awareness and practice of familial hypercholesterolemia at academic institutes in Jeddah, Saudi Arabia.
Alzahrani SH; Bima A; Algethami MR; Awan Z
Lipids Health Dis; 2020 May; 19(1):101. PubMed ID: 32438925
[TBL] [Abstract][Full Text] [Related]
8. Transitioning from pediatric to adult health care with familial hypercholesterolemia: Listening to young adult and parent voices.
Sliwinski SK; Gooding H; de Ferranti S; Mackie TI; Shah S; Saunders T; Leslie LK
J Clin Lipidol; 2017; 11(1):147-159. PubMed ID: 28391881
[TBL] [Abstract][Full Text] [Related]
9. Development of an Implementation Framework for Overcoming Underdiagnoses of Familial Hypercholesterolemia in the USA.
Miller DM; Gaviglio A; Zierhut HA
Public Health Genomics; 2021; 24(3-4):110-122. PubMed ID: 33853081
[TBL] [Abstract][Full Text] [Related]
10. Healthcare Utilization and Patients' Perspectives After Receiving a Positive Genetic Test for Familial Hypercholesterolemia.
Jones LK; Kulchak Rahm A; Manickam K; Butry L; Lazzeri A; Corcoran T; Komar D; Josyula NS; Pendergrass SA; Sturm AC; Murray MF
Circ Genom Precis Med; 2018 Aug; 11(8):e002146. PubMed ID: 30354341
[TBL] [Abstract][Full Text] [Related]
11. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
Goldberg AC; Hopkins PN; Toth PP; Ballantyne CM; Rader DJ; Robinson JG; Daniels SR; Gidding SS; de Ferranti SD; Ito MK; McGowan MP; Moriarty PM; Cromwell WC; Ross JL; Ziajka PE;
J Clin Lipidol; 2011 Jun; 5(3 Suppl):S1-8. PubMed ID: 21600525
[TBL] [Abstract][Full Text] [Related]
12. Acceptability, Appropriateness, and Feasibility of Automated Screening Approaches and Family Communication Methods for Identification of Familial Hypercholesterolemia: Stakeholder Engagement Results from the IMPACT-FH Study.
Jones LK; Walters N; Brangan A; Ahmed CD; Gatusky M; Campbell-Salome G; Ladd IG; Sheldon A; Gidding SS; McGowan MP; Rahm AK; Sturm AC
J Pers Med; 2021 Jun; 11(6):. PubMed ID: 34205662
[TBL] [Abstract][Full Text] [Related]
13. Familial hypercholesterolemia: screening, diagnosis and management of pediatric and adult patients: clinical guidance from the National Lipid Association Expert Panel on Familial Hypercholesterolemia.
Goldberg AC; Hopkins PN; Toth PP; Ballantyne CM; Rader DJ; Robinson JG; Daniels SR; Gidding SS; de Ferranti SD; Ito MK; McGowan MP; Moriarty PM; Cromwell WC; Ross JL; Ziajka PE
J Clin Lipidol; 2011; 5(3):133-140. PubMed ID: 21600517
[TBL] [Abstract][Full Text] [Related]
14. Rationale and design of the familial hypercholesterolemia foundation CAscade SCreening for Awareness and DEtection of Familial Hypercholesterolemia registry.
O'Brien EC; Roe MT; Fraulo ES; Peterson ED; Ballantyne CM; Genest J; Gidding SS; Hammond E; Hemphill LC; Hudgins LC; Kindt I; Moriarty PM; Ross J; Underberg JA; Watson K; Pickhardt D; Rader DJ; Wilemon K; Knowles JW
Am Heart J; 2014 Mar; 167(3):342-349.e17. PubMed ID: 24576518
[TBL] [Abstract][Full Text] [Related]
15. Significant gaps in awareness of familial hypercholesterolemia among physicians in selected Asia-Pacific countries: a pilot study.
Pang J; Sullivan DR; Harada-Shiba M; Ding PY; Selvey S; Ali S; Watts GF
J Clin Lipidol; 2015; 9(1):42-8. PubMed ID: 25670359
[TBL] [Abstract][Full Text] [Related]
16. Prevalence and management of familial hypercholesterolemia in patients with coronary artery disease: The heredity survey.
Faggiano P; Pirillo A; Griffo R; Ambrosetti M; Pedretti R; Scorcu G; Werren M; Febo O; Malfatto G; Favretto G; Sarullo F; Antonini-Canterin F; Zobbi G; Temporelli P; Catapano AL;
Int J Cardiol; 2018 Feb; 252():193-198. PubMed ID: 29249427
[TBL] [Abstract][Full Text] [Related]
17. Social cognition correlates of self-management behaviors in patients with familial hypercholesterolemia (FH): A meta-analytic review.
Majeed R; Hamilton K; Watts GF; Hagger MS
Soc Sci Med; 2024 Jun; 351():116968. PubMed ID: 38759387
[TBL] [Abstract][Full Text] [Related]
18. Patient and Provider Perspectives on a Decision Aid for Familial Hypercholesterolemia.
Farwati M; Kumbamu A; Kochan DC; Kullo IJ
J Pers Med; 2018 Nov; 8(4):. PubMed ID: 30400379
[TBL] [Abstract][Full Text] [Related]
19. An insight into familial hypercholesterolemia in Greece: rationale and design of the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH).
Rizos CV; Athyros V; Bilianou E; Chrousos G; Garoufi A; Kolovou G; Kotsis V; Rallidis L; Skalidis E; Skoumas I; Tziomalos K; Liberopoulos EN
Hormones (Athens); 2017 Jul; 16(3):306-312. PubMed ID: 30091117
[TBL] [Abstract][Full Text] [Related]
20. A Tale of 2 Constituencies: Exploring Patient and Clinician Perspectives in the Age of Big Data.
Goytia CN; Kastenbaum I; Shelley D; Horowitz CR; Kaushal R
Med Care; 2018 Oct; 56 Suppl 10 Suppl 1(10 Suppl 1):S64-S69. PubMed ID: 30074954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
